Moreover, we demonstrated for the first time that iNOP-7 could deliver clinically-relevant amounts of PLK1 siRNA to lung tumors and reduce their proliferation in an orthotopic NSCLC mouse model which closely mimics the tumor microenvironment observed in the clinical setting. Here, PLK1 is linked to non-small cell lung carcinoma.